Paul Stacey
Director of Finance/CFO chez GABY INC.
Fortune : 1 667 $ au 31/03/2024
Profil
Paul Stacey is currently the Chief Financial Officer & Vice President at GABY, Inc. He previously worked as the Chief Financial Officer at Metagreen and The Hempshire Group, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GABY, INC.
0,05% | 20/06/2023 | 333 333 ( 0,05% ) | 1 667 $ | 31/03/2024 |
Postes actifs de Paul Stacey
| Sociétés | Poste | Début |
|---|---|---|
| GABY INC. | Director of Finance/CFO | 01/03/2022 |
Anciens postes connus de Paul Stacey
| Sociétés | Poste | Fin |
|---|---|---|
| THE HEMPSHIRE GROUP, INC. | Director of Finance/CFO | 14/02/2024 |
Metagreen
 Metagreen Pharmaceuticals: OtherHealth Technology Metagreen provides health care and pharmaceutical technology services. It develops novopure technology for extraction and clarionworks technology for purification and formulations. The company was founded by Randall B. Murphy in 2015 and is headquartered in Los Angeles, CA. | Director of Finance/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GABY INC. | Consumer Non-Durables |
| THE HEMPSHIRE GROUP, INC. | Consumer Non-Durables |
| Entreprise privées | 1 |
|---|---|
Metagreen
Metagreen Pharmaceuticals: OtherHealth Technology Metagreen provides health care and pharmaceutical technology services. It develops novopure technology for extraction and clarionworks technology for purification and formulations. The company was founded by Randall B. Murphy in 2015 and is headquartered in Los Angeles, CA. | Health Technology |
